Status:
COMPLETED
Can the Electronic Nose Smell COVID-19 Antibodies?
Lead Sponsor:
Maastricht University Medical Center
Conditions:
SARS-CoV Infection
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Corona Virus Disease (COVID-19), spread worldwide and has become an emergency of major international concern. In March 2020, the WHO declared the COVID-19 outbreak a global pandemic. Accurate and fast...
Eligibility Criteria
Inclusion
- Participants of whom an oropharyngeal and nasopharyngeal swab was collected for RT-PCR and on whom serology testing for the detection of antibodies was performed.
Exclusion
- Participants who where experiencing dyspnea or needed supplemental oxygen.
Key Trial Info
Start Date :
April 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
222 Patients enrolled
Trial Details
Trial ID
NCT04475575
Start Date
April 6 2020
End Date
July 1 2020
Last Update
July 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, Netherlands, 6229 HX